Ulteriori informazioni
Zusatztext . . . a broad and encompassing resource . . . the chapters are stellar in their readability and informative nature . . . well written, well organized, and well referenced. Klappentext This is the first book on mild cognitive impairment (MCI), the transitional period between normal aging and very early Alzheimer's disease (AD). Persons with MCI have an increased risk of developing AD. This book addresses the spectrum of issues involved in MCI, and includes chapters on clinical studies, neuropsychology, neuroimaging, neuropathology, biological markers, diagnostic approaches, and treatment. It is intended for individuals interested in aging and cognition, among them neurologists, psychiatrists, geri-atricians, clinical psychologists, neuropsychologists, and their students and trainees. Zusammenfassung This book examines mild cognitive impairment (MCI), the transitional period between normal ageing and very early Alzheimer's disease (AD). It addresses the issues involved and includes chapters on clinical studies, neuropsychology, neuroimaging, neuropathology, biological markers, diagnostic approaches, and treatment. Inhaltsverzeichnis 1: Ronald C. Petersen: Conceptual Overview 2: Ronald C. Petersen and John C. Morris: Clinical features 3: Jeffrey L. Cummings: Neuropsychiatric symptoms 4: Glenn E. Smith and Robert J. Ivnik: Normative neuropsychology in ageing and Mild Cognitive Impairment 5: Martin Sliwinski, Richard Lipton, Herman Buschke and Christina Wasylyshyn: Optimizing cognitive test norms for detection 6: Clifford R. Jack, Jr: Magnetic resonance imaging 7: Marilyn S. Albert and Keith A. Johnson: Functional imaging 8: Heiko Braak and Eva Braak: Spectrum of pathology 9: Bradley T. Hyman and Teresa Gomez-Isla: Neuropathological changes in normal aging, mild cognitive impairment and Alzheimer's disease 10: Neill R. Graff-Radford and Steven G. Younkin: Biological markers 11: Ronald C. Petersen: Clinical evaluation 12: David S. Knopman: Treatment of mild cognitive impairment and prospects for prevention of Alzheimer's disease ...
